Clinical practice guidelines for the management of endocrine hormones associated with frailty in the elderly in China

Title: Clinical practice guidelines for the management of endocrine hormones associated with frailty in the elderly in China
Edition: Original
Classification: Standard guideline
Field: Diagnosis and Treatment
Countries and regions: China
Guidelines users:
Evidence classification method: The recommendations in this guideline are divided into five levels according to the strength of evidence-based medicine: A strong recommendation, positive evidence, can improve health outcomes, and the benefits outweigh the risks; B recommendation, which is well documented to improve health outcomes and does more good than harm; C Not recommended or routinely recommended, with evidence of improved health outcomes but with nearly equal benefits; D against recommendation because the evidence is not strong or would cause more harm than good to health outcomes; I Evidence is lacking, or of poor quality, or contradictory to determine the benefits and harms of health outcomes
Development unit: 中南大学湘雅二医院
Registration time: 2022-08-09
Registration number: PREPARE-2022CN457
Purpose of the guideline: